Who is sponsoring NCT03551613?

NCT03551613 is sponsored by Ain Shams University.

What drugs are being tested in NCT03551613?

Interventions in NCT03551613: honey supplementation.

What condition does NCT03551613 study?

NCT03551613 studies Malnourished Infants and Childern.

Is NCT03551613 still recruiting?

NCT03551613 is currently completed. Last updated 11 June 2018.

Last reviewed 2018-06-11 · How we verify

NCT03551613

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Honey Supplementation on Serum Leptin in Malnourished Infants and Children

Completed NA Last updated 11 June 2018

What this trial tests

NA trial testing honey supplementation in Malnourished Infants and Childern in 75 participants. Completed in 25 February 2018.

Timeline

12 December 2016

Primary endpoint
12 November 2017

25 February 2018

Quick facts

Lead sponsor	Ain Shams University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	75
Start date	12 December 2016
Primary completion	12 November 2017
Estimated completion	25 February 2018

Drugs / interventions tested

honey supplementation

Conditions studied

Malnourished Infants and Childern — all drugs for Malnourished Infants and Childern →

Sponsor

Ain Shams University

Who can join

Adults 6 Months to 3, any sex, with Malnourished Infants and Childern. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was a randomized single blinded case control prospective intervention study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03551613 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 11 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03551613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing